MX2020008677A - Novel salmonella heidelberg bacteriophage sal-hep-1 and use thereof for inhibiting growth of salmonella heidelberg bacteria. - Google Patents

Novel salmonella heidelberg bacteriophage sal-hep-1 and use thereof for inhibiting growth of salmonella heidelberg bacteria.

Info

Publication number
MX2020008677A
MX2020008677A MX2020008677A MX2020008677A MX2020008677A MX 2020008677 A MX2020008677 A MX 2020008677A MX 2020008677 A MX2020008677 A MX 2020008677A MX 2020008677 A MX2020008677 A MX 2020008677A MX 2020008677 A MX2020008677 A MX 2020008677A
Authority
MX
Mexico
Prior art keywords
salmonella heidelberg
hep
sal
bacteria
bacteriophage
Prior art date
Application number
MX2020008677A
Other languages
Spanish (es)
Inventor
Jee Soo Son
Soo Youn Jun
Sang Hyeon Kang
Seong Jun Yoon
Hyoun Rok Paik
Ji Young Seo
Original Assignee
Intron Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intron Biotechnology Inc filed Critical Intron Biotechnology Inc
Publication of MX2020008677A publication Critical patent/MX2020008677A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to: a Podoviridae bacteriophage Sal-HEP-1 (accession number: KCTC 13454BP) isolated from nature, the Podoviridae bacteriophage Sal-HEP-1 having the ability to kill Salmonella Heidelberg bacteria and having a genome represented by SEQ ID NO: 1; and a method for preventing and treating diseases induced by the Salmonella Heidelberg bacteria by using a composition containing the Podoviridae bacteriophage Sal-HEP-1 as an active ingredient.
MX2020008677A 2018-02-21 2019-02-18 Novel salmonella heidelberg bacteriophage sal-hep-1 and use thereof for inhibiting growth of salmonella heidelberg bacteria. MX2020008677A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180020495A KR102041109B1 (en) 2018-02-21 2018-02-21 Novel Salmonella Heidelberg bacteriophage Sal-HEP-1 and its use for preventing proliferation of Salmonella Heidelberg
PCT/KR2019/001896 WO2019164194A1 (en) 2018-02-21 2019-02-18 Novel salmonella heidelberg bacteriophage sal-hep-1 and use thereof for inhibiting growth of salmonella heidelberg bacteria

Publications (1)

Publication Number Publication Date
MX2020008677A true MX2020008677A (en) 2020-09-25

Family

ID=67686843

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008677A MX2020008677A (en) 2018-02-21 2019-02-18 Novel salmonella heidelberg bacteriophage sal-hep-1 and use thereof for inhibiting growth of salmonella heidelberg bacteria.

Country Status (5)

Country Link
KR (1) KR102041109B1 (en)
BR (1) BR112020016029A2 (en)
CO (1) CO2020010533A2 (en)
MX (1) MX2020008677A (en)
WO (1) WO2019164194A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11058131B2 (en) 2015-04-16 2021-07-13 Kennesaw State University Research And Service Foundation, Inc. Escherichia coli O157:H7 bacteriophage Φ241
KR20240003147A (en) * 2022-06-30 2024-01-08 주식회사 옵티팜 Novel Salmonella enterica specific bacteriophage OPT-SAL01 and antibacterial composition comprising the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005024005A1 (en) * 2003-09-03 2005-03-17 Intralytix, Inc. Novel salmonella bacteriophage and uses thereof
KR101021041B1 (en) * 2008-06-09 2011-03-15 주식회사 인트론바이오테크놀로지 A composition for treating ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
KR101261873B1 (en) * 2011-08-23 2013-05-14 대한민국 (식품의약품안전처장) Bacteriophage having bacteriocidal effect on Salmonella spp., the cause of sitotoxism
KR101432872B1 (en) * 2011-09-20 2014-08-27 씨제이제일제당 (주) Novel bacteriophage and antibacterial composition comprising the same
KR101591789B1 (en) * 2014-04-15 2016-02-04 씨제이제일제당(주) Novel bacteriophage and composition comprising the same
KR101761573B1 (en) * 2014-12-29 2017-07-26 주식회사 인트론바이오테크놀로지 Novel enterohemorrhage Escherichia coli bacteriophage Esc-CHP-1 and its use for preventing proliferation of enterohemorrhage Escherichia coli

Also Published As

Publication number Publication date
WO2019164194A1 (en) 2019-08-29
KR102041109B1 (en) 2019-11-27
KR20190100663A (en) 2019-08-29
CO2020010533A2 (en) 2020-11-30
BR112020016029A2 (en) 2020-12-08

Similar Documents

Publication Publication Date Title
MX2017008561A (en) Novel clostridium perfringens bacteriophage clo-pep-1 and use thereof for inhibiting proliferation of clostridium perfringens.
MX2017008563A (en) Novel shigatoxin-producing f18 type e. coli bacteriophage esc-cop-1 and use thereof for inhibiting proliferation of shigatoxin-producing f18 type e. coli.
MX2017008562A (en) Novel enteroinvasive e. coli bacteriophage esc-cop-4 and use thereof for inhibiting proliferation of enteroinvasive e. coli.
WO2021226436A8 (en) Optimized nucleotide sequences encoding sars-cov-2 antigens
MX2019009964A (en) Novel clostridium perfringens bacteriophage clo-pep-2 and use for inhibiting clostridium perfringens proliferation of same.
WO2018155813A3 (en) Novel antibacterial protein efal-2 having bacteriolytic ability with respect to enterococcus faecium
ES2682670T3 (en) Streptococcus bacteriophage lysines for the detection and treatment of gram positive bacteria
MX2019002978A (en) Compositions comprising a non-pathogenic bacteria and methods for protecting plant and animal hosts from fungal, bacterial and viral diseases.
PH12020500406A1 (en) Treatment of mosaic viruses and bacterial infections of plants
MX2022000453A (en) Compounds useful to treat influenza virus infections.
BR112018012044A2 (en) bacteriophage pas-mup-1 from innovative pasteurella multocida and use of it to inhibit the proliferation of pasteurella multocida
WO2019235782A8 (en) Novel streptococcus suis bacteriophage str-sup-2, and use thereof for inhibiting proliferation of streptococcus suis strains
MX2021005518A (en) Animal models, screening methods, and treatment methods for intraocular diseases or disorders.
MX2020008677A (en) Novel salmonella heidelberg bacteriophage sal-hep-1 and use thereof for inhibiting growth of salmonella heidelberg bacteria.
WO2019045248A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
MX2021007524A (en) Rifamycin analogs and antibody-drug conjugates thereof.
MX2016010794A (en) Bioactive protein, use thereof and method for its production.
WO2018097603A3 (en) Middle east respiratory syndrome coronavirus s protein immunogenic composition and method for preparing same
WO2019235783A8 (en) Novel streptococcus suis bacteriophage str-sup-3, and use thereof for inhibiting proliferation of streptococcus suis strains
WO2019039781A3 (en) Novel aeromonas salmonicida bacteriophage aer-sap-2 and use thereof in inhibiting proliferation of aeromonas salmonicida bacteria
WO2011155727A3 (en) Method for preventing and treating infection caused by salmonella choleraesuis or salmonella dublin
WO2018236086A3 (en) Novel aeromonas hydrophila bacteriophage aer-hyp-2 and use thereof in preventing proliferation of aeromonas hydrophila
WO2018117462A3 (en) Novel vibrio parahaemolyticus bacteriophage vib-pap-4 and use thereof in inhibiting proliferation of vibrio parahaemoliticus bacteria
WO2018101595A3 (en) Escherichia coli bacteriophage esc-cop-9 and use for inhibiting proliferation of pathogenic escherichia coli thereof
MX2021000949A (en) New attenuated virus strain and use thereof as a vaccine.